Company Filing History:
Years Active: 1999-2003
Title: Michael A Dalton: Innovator in Molecular Biology
Introduction
Michael A Dalton is a prominent inventor based in Manchester, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of recombinant DNA technology. With a total of 6 patents to his name, Dalton's work has advanced the understanding and application of restriction endonucleases and methylases.
Latest Patents
Dalton's latest patents include a method for cloning and expression of TspRI restriction endonuclease and TspRI methylase in E. coli. This invention relates to recombinant DNA that encodes the TspRI restriction endonuclease as well as TspRI methylase, facilitating their expression in cells containing the recombinant DNA. Another notable patent is for a method for cloning and producing the SwaI restriction endonuclease. This invention involves recombinant DNA that encodes the SwaI restriction endonuclease and modification methylase, along with the production of SwaI restriction endonuclease from the recombinant DNA. Related expression vectors, pHKUV5 and pHKT7, are also disclosed, featuring strong promoters and specific replication origins.
Career Highlights
Michael A Dalton is currently associated with New England Biolabs, Inc., where he continues to innovate in the field of molecular biology. His work has been instrumental in developing tools that are widely used in genetic research and biotechnology.
Collaborations
Dalton has collaborated with notable colleagues such as Huimin Kong and Lauren Sears Higgins, contributing to various projects that enhance the capabilities of molecular biology research.
Conclusion
Michael A Dalton's contributions to the field of molecular biology through his patents and collaborations have made a lasting impact on genetic research and biotechnology. His innovative methods continue to pave the way for advancements in the industry.